Evidence map›Paper›PMID 39168134›Full record

ArticleHomeopathy : the journal of the Faculty of Homeopathy2025

Characterisation of Aqueous Ultra-high Homeopathic Potencies: Nanoparticle Tracking Analysis.

Michel Van Wassenhoven, Martine Goyens, Pierre Dorfman, Philippe Devos, Jean-Louis Demangeat

Abstract read
In one paragraph

Article in Homeopathy : the journal of the Faculty of Homeopathy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michel Van WassenhovenCoordinator of DynHom Research Project, Chastre, Belgium.ORCID 0000-0002-6164-9001
Martine GoyensPharmaceutical Association for Homeopathy, Wépion, Belgium.
Pierre DorfmanM.R.C. Endowment Fund, Private Academy of Science™, Meyzieu, France.
Philippe DevosUnio Homoeopathica Belgica, Evergem, Belgium.
Jean-Louis DemangeatNuclear Medicine Department, General Hospital, Haguenau, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesOver the past decade, research using various methods has claimed the material nature, including nanoparticles (NPs), of high homeopathic potencies. The current study aims to verify these findings using NP tracking analysis (NTA).

methodsSix independent serial dilutions of commonly used homeopathic medicines-either soluble (

resultsWe observed the presence of particles from 20 to 300-400 nm in all DYNs, DILs and controls, except in pure unstirred water. The sizes and size distributions of NPs in high homeopathic potencies were smaller than those in controls for soluble sources and larger for insoluble sources, even above 11cH. The opposite behaviour was observed in the number of NPs. When comparing DYN and DIL, the number, size, presence of aggregates or chains and brightness of NPs increased with DYNs, which was also observed above 11cH. Many NPs scattered light of low intensity, indicating the presence of material particles. The container had a significant effect on the number and size of NPs, indicating the involvement of the atmosphere and leaching processes.

conclusionHomeopathic medicines contain NPs with specific properties, even when diluted beyond Avogadro's number. Homeopathic potentisation is not a simple dilution. The starting material, the solvent used, the type of container and the manufacturing method influence the characteristics of these NPs. The nature of these NPs is not known, but most likely they are a mixture of nanobubbles and elements from the atmosphere and container, including insoluble ones.

Indexed as

HomeopathyMateria MedicaNanoparticlesHumansParticle SizeWaterMateria MedicaWater

Identifiers

PMID39168134
PMCPMC12283143

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.